Are you at #ISTH2024 and interested in Antithrombin deficiency? Check out our poster on - Developing cell-based genome editing approach for antithrombin deficiency: a therapeutic prospect (PB0561), Monday 24th at the Exhibition hall 13:45-14:45. @Oslounivsykehus@UniOslo_MED
Are you at #EHA2024 and interested in new treatment methods for bleeding disorders? Go see @mechollet talk about "Autologous gene-corrected stem cell-derived hepatic organoids for the treatment of FVII deficiency" tomorrow at 16:45.
https://t.co/9D1S3BwmKr
Opening of Norway Life Science 2024; Minister of research and higher education Oddmund Hoel and Director of Health Data Research UK Prof Andrew Morris on utilizing health data!
Excited to be here🙌 @UiO_LifeSci
We are excited to announce that our project “Autologous cell-based therapy for coagulation factor deficiency “ is admitted to the SPARK Norway program! Thank you @UiO_LifeSci !
#Innovation#celltherapy#bloodcoagulation
https://t.co/WdI5kt3MHc
This week, @mechollet presented her work «Modeling and correcting FVII deficiency using human stem cell-derived hepatic organoids» at the #ISTH2023 in Montreal, Canada. Grateful for the opportunity and Thanks to @helsesorost for making it possible! @RIIM_UiO_OUS@Oslounivsykehus
This week, @GiacomoRoman_ presented his work «Autologous CRISPR/Cas9 correction of a missense variant from a patient with severe, inherited FVII deficiency» at the #ISTH2023. Grateful for the opportunity and Thanks @forskningsradet for making it possible! @UniOslo@RIIM_UiO_OUS
Excited to be back at #ISTH2023 in Montreal! Today our @GiacomoRoman_ and @mechollet will present their work on autologous CRISPR correction and modeling of FVII deficiency using hepatic organoids. OC 7 Rare Bleeding Disorders I in room 524 at 1:00 PM.
@Oslounivsykehus@UniOslo
Congratulations Marit Engeseth on completing your PhD "Clinical implications of post-thrombotic syndrome" yesterday! Great work by opponents @SimonNoble & @DahlMichelsenT and cudos to supervisors Hilde Skuterud Wik, Tone Enden and @psandset!
We know about the heart-brain and brain-gut interactive axis. Now there's the liver-heart:
A clotting factor (FXI) made in the liver protects the heart (unexpectedly) from failure
https://t.co/vG2cFlo0Jg
https://t.co/4BqeHEiMyu
The importance of investigating the bone marrow microenvironment in precursor stages of myeloma.
See interview by @XueyanCui from our lab during the annual meeting of the @isth in London. @UniOslo@Oslounivsykehus
https://t.co/HxVVbkzNio
Antithrombin deficiency not detected by current assays - important new info regarding importance of sugar entities. Great collaboration: @ugedelamorbar Javier Corral @morange_pierre@psandset@UniOslo
https://t.co/d8yz7vcMA4!
At #ISTH2022, interested in Factor VII Activating Protease (FSAP)? Check out PB1256 - The role of FSAP in regulating endothelial permeability at today’s poster session, starting at 6.30 PM. @RIIM_UiO_OUS@Oslounivsykehus@UniOslo
@isth Check out PB0596 - Anti-SARS-CoV-2 vaccines do not induce a hypercoagulable state in healthy individuals at today’s poster session! By Lamya Garabet and co-workers @sykehusostfold, @UNN_HF@RIIM_UiO_OUS, @Oslounivsykehus and @UniOslo
https://t.co/TkSWnqWfYP
@isth If you are interested in drug repurposing, check out PB0700 - Evaluation of Pharmacological Enhancers of Mutated Factor VII Activity ex vivo and meet Marianne at today’s poster session! https://t.co/Vo5kr5qhPY
@RIIM_UiO_OUS@Oslounivsykehus@UniOslo
Finally back @isth, in LONDON! Check out this interesting poster by our Xueyan Cui at todays session from 6.30 PM: PB0779 - Low expression of coagulation inhibitors in the immune microenvironment in precursor stages of multiple myeloma. @RIIM_UiO_OUS@Oslounivsykehus@UniOslo
Congratulation to PhD Ragnhild J Måseide for excellent defense of her thesis “Moderate haemophilia A and B in the Nordic countries – The MoHem study”! Compliments also to Prof. John Pasi and Prof. Anna-Elina Lehtinen for great opposition and supervisors PA Holme and G Tjønnfjord.